Literature DB >> 23461056

Angiotensin-converting enzyme inhibitor-induced angioedema.

Abduljabar A Theyab1, David S Lee, Amor Khachemoune.   

Abstract

Angiotensin-converting enzyme (ACE) inhibitors frequently are prescribed for the management of cardiovascular disorders. In addition to their therapeutic potential, ACE inhibitors are associated with numerous adverse effects, some of which may be lethal. Angioedema is an uncommon but serious acute event that may affect any individual taking an ACE inhibitor. This review outlines the advances in our understanding of the pathogenesis, clinical presentation, and management of this medical emergency.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23461056

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  2 in total

1.  ACE-inhibitor induced angio-oedema treated with complement C1-inhibitor concentrate.

Authors:  Eva Rye Rasmussen; Anette Bygum
Journal:  BMJ Case Rep       Date:  2013-10-04

2.  Angioedema Triggered by Medication Blocking the Renin/Angiotensin System: Retrospective Study Using the French National Pharmacovigilance Database.

Authors:  Charles Faisant; Guillaume Armengol; Laurence Bouillet; Isabelle Boccon-Gibod; Céline Villier; Hervé Lévesque; Judith Cottin; Nathalie Massy; Ygal Benhamou
Journal:  J Clin Immunol       Date:  2015-12-28       Impact factor: 8.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.